Title |
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma |
|---|---|
Involved |
Christine Dierks (Verfasser)
Jochen Seufert (Verfasser) Konrad Aumann (Verfasser) Juri Ruf (Verfasser)
Claudius Klein (Verfasser)
Selina Kiefer (Verfasser) Michael Rassner (Verfasser) Melanie Börries (Verfasser) Andreas Zielke (Verfasser) Paul La Rosée (Verfasser) Philipp Tobias Meyer (Verfasser) Matthias Kroiß (Verfasser) Christian Weißenberger (Verfasser) Tilmann Schumacher (Verfasser) Patrick Metzger (Verfasser) Harald Weiss (Verfasser) Constantin Smaxwil (Verfasser) Katharina Laubner (Verfasser) Justus Duyster (Verfasser) Nikolas von Bubnoff (Verfasser) Cornelius Miething (Verfasser) Oliver Thomusch (Verfasser) |
Published |
Freiburg: Universität |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
Endocrinology, diabetes and metabolism |
DDC notation |
|
Persistent identifier |
urn:nbn:de:bsz:25-freidok-1944270 (URN) |
Further information |
Thyroid. - 31, 7 (2021) , 1076–1085, ISSN: 1557-9077 |
Record ID |
1247431207 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: